376 related articles for article (PubMed ID: 36141654)
1. Oral Lesions Associated with COVID-19 and the Participation of the Buccal Cavity as a Key Player for Establishment of Immunity against SARS-CoV-2.
Gutierrez-Camacho JR; Avila-Carrasco L; Martinez-Vazquez MC; Garza-Veloz I; Zorrilla-Alfaro SM; Gutierrez-Camacho V; Martinez-Fierro ML
Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141654
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and oral diseases: Assessing manifestations of a new pathogen in oral infections.
Naqvi AR; Schwartz J; Brandini DA; Schaller S; Hussein H; Valverde A; Naqvi RA; Shukla D
Int Rev Immunol; 2022; 41(4):423-437. PubMed ID: 34525891
[TBL] [Abstract][Full Text] [Related]
3. The spectrum of non-characteristic oral manifestations in COVID-19 - a scoping brief commentary.
Hüpsch-Marzec H; Dziedzic A; Skaba D; Tanasiewicz M
Med Pr; 2021 Dec; 72(6):685-692. PubMed ID: 34596170
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 manifestation in the oral cavity - a narrative literature review.
Kusiak A; Cichońska D; Tubaja M; Skorek A; Jereczek-Fossa BA; Corrao G; Marvaso G; Alterio D
Acta Otorhinolaryngol Ital; 2021 Oct; 41(5):395-400. PubMed ID: 34734574
[TBL] [Abstract][Full Text] [Related]
5. Oral mucosal lesions and oral symptoms of the SARS-CoV-2 infection.
Surboyo MD; Ernawati DS; Budi HS
Minerva Dent Oral Sci; 2021 Aug; 70(4):161-168. PubMed ID: 34269548
[TBL] [Abstract][Full Text] [Related]
6. An update on oral clinical courses among patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A clinical follow-up (a prospective prevalent cohort) study.
Gebretsadik HG
PLoS One; 2022; 17(10):e0275817. PubMed ID: 36269692
[TBL] [Abstract][Full Text] [Related]
7. [Manifestation of SARS-CoV-2 infection on oral mouth mucosa].
Laskowska E; Radwan-Oczko M
Pol Merkur Lekarski; 2021 Oct; 49(293):374-378. PubMed ID: 34800028
[TBL] [Abstract][Full Text] [Related]
8. Is the oral cavity relevant in SARS-CoV-2 pandemic?
Herrera D; Serrano J; Roldán S; Sanz M
Clin Oral Investig; 2020 Aug; 24(8):2925-2930. PubMed ID: 32577830
[TBL] [Abstract][Full Text] [Related]
9. Autoimmunity and COVID-19 - The microbiotal connection.
Katz-Agranov N; Zandman-Goddard G
Autoimmun Rev; 2021 Aug; 20(8):102865. PubMed ID: 34118455
[TBL] [Abstract][Full Text] [Related]
10. Estimating the viral loads of SARS-CoV-2 in the oral cavity when complicated with periapical lesions.
Altaie AM; Hamdy R; Venkatachalam T; Hamoudi R; Soliman SSM
BMC Oral Health; 2021 Nov; 21(1):567. PubMed ID: 34749700
[TBL] [Abstract][Full Text] [Related]
11. COVID-19-related oral mucosa lesions among confirmed SARS-CoV-2 patients: a systematic review.
Erbaş GS; Botsali A; Erden N; Arı C; Taşkın B; Alper S; Vural S
Int J Dermatol; 2022 Jan; 61(1):20-32. PubMed ID: 34549816
[TBL] [Abstract][Full Text] [Related]
12. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era.
Frank S; Capriotti J; Brown SM; Tessema B
Ear Nose Throat J; 2020 Nov; 99(9):586-593. PubMed ID: 32520599
[TBL] [Abstract][Full Text] [Related]
13. Oral Health Implications of SARS-CoV-2/COVID-19: A Systematic Review.
Doceda MV; Gavriiloglou M; Petit C; Huck O
Oral Health Prev Dent; 2022 Apr; 20(1):207-218. PubMed ID: 35481345
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 and Its Repercussions on Oral Health: A Review.
Rusu LC; Ardelean LC; Tigmeanu CV; Matichescu A; Sauciur I; Bratu EA
Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833407
[TBL] [Abstract][Full Text] [Related]
15. Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ?
Brandão TB; Gueiros LA; Melo TS; Prado-Ribeiro AC; Nesrallah ACFA; Prado GVB; Santos-Silva AR; Migliorati CA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Feb; 131(2):e45-e51. PubMed ID: 32888876
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
17. Association of Viral Infections With Oral Cavity Lesions: Role of SARS-CoV-2 Infection.
La Rosa GRM; Libra M; De Pasquale R; Ferlito S; Pedullà E
Front Med (Lausanne); 2020; 7():571214. PubMed ID: 33521007
[TBL] [Abstract][Full Text] [Related]
18. Oral mucosal lesions in patients with SARS-CoV-2 infection. Report of four cases. Are they a true sign of COVID-19 disease?
Cruz Tapia RO; Peraza Labrador AJ; Guimaraes DM; Matos Valdez LH
Spec Care Dentist; 2020 Nov; 40(6):555-560. PubMed ID: 32882068
[TBL] [Abstract][Full Text] [Related]
19. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
20. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
